| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 38.09▲ | 37.88▲ | 37.94▲ | 36.79▲ | 32.81▲ |
| MA10 | 37.96▲ | 37.88▲ | 37.86▲ | 35.28▲ | 32.67▲ |
| MA20 | 37.91▲ | 37.77▲ | 37.71▲ | 33.09▲ | 32.70▲ |
| MA50 | 37.89▲ | 37.32▲ | 35.60▲ | 32.48▲ | 36.90▲ |
| MA100 | 37.82▲ | 35.48▲ | 33.82▲ | 32.75▲ | 38.59▼ |
| MA200 | 37.66▲ | 33.60▲ | 32.79▲ | 36.19▲ | 36.60▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.045▲ | -0.030▼ | -0.092▼ | 0.694▲ | 0.659▲ |
| RSI | 68.271▲ | 63.731▲ | 67.147▲ | 76.169▲ | 59.134▲ |
| STOCH | 95.454▲ | 47.130 | 69.940 | 79.739 | 53.864 |
| WILL %R | -13.008▲ | -10.526▲ | -5.714▲ | -3.176▲ | -2.619▲ |
| CCI | 180.688▲ | 145.902▲ | 103.133▲ | 130.686▲ | 268.843▲ |
|
Tuesday, August 12, 2025 11:48 AM
Xenon Pharmaceuticals is advancing azetukalner in multiple phase 3 trials for focal onset seizures, with topline X-TOLE2 data expected in early 2026. Azetukalner's mechanism and prior dose-dependent ...
|
|
Tuesday, August 12, 2025 12:35 AM
Xenon Pharmaceuticals Inc (XENE) showcases robust financial health and clinical progress, with promising developments in epilepsy and depression treatments.
|
|
Monday, August 11, 2025 08:45 PM
Discover key insights from Xenon Pharmaceuticals' Q2 2025 earnings call, including milestones in epilepsy, depression trials, and a strong cash ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/08/25 | 38.14 | 38.50 | 37.3201 | 38.23 | 806,783 |
| 14/08/25 | 37.39 | 38.27 | 36.86 | 37.96 | 763,360 |
| 13/08/25 | 36.24 | 38.045 | 35.977 | 37.67 | 1,546,096 |
| 12/08/25 | 36.00 | 37.5816 | 35.10 | 35.99 | 1,946,257 |
| 11/08/25 | 33.27 | 34.42 | 32.78 | 34.11 | 1,100,501 |
| 08/08/25 | 33.57 | 33.87 | 32.84 | 33.43 | 865,100 |
| 07/08/25 | 34.31 | 34.633 | 32.925 | 33.63 | 602,900 |
| 06/08/25 | 34.11 | 34.50 | 33.692 | 34.27 | 752,400 |
| 05/08/25 | 33.40 | 36.68 | 33.18 | 34.40 | 2,361,800 |
| 04/08/25 | 30.71 | 33.23 | 30.65 | 33.16 | 1,841,505 |
|
|
||||
|
|
||||
|
|